Long-term levetiracetam treatment in patients with epilepsy: 3-year follow up

Acta Neurologica Scandinavica

Volumn 121, Issue 2, 2010, Pages 83-88

  Kuba, R ^a   Novotna I ^a   Brazdil M ^a   Kocvarova J ^a   Tyrlikova I ^a   Mastik J ^a   Rektor, I ^a  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

Efficacy; Epilepsy; Levetiracetam; Long term; Retention rate; Tolerability

Indexed keywords

ETIRACETAM;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; AGGRESSION; ARTICLE; ASTHENIA; ATAXIA; COMORBIDITY; DEPRESSION; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; FEMALE; FOCAL EPILEPSY; FOLLOW UP; HEADACHE; HUMAN; IMPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MONOTHERAPY; MOOD; NEUROSURGERY; RETROSPECTIVE STUDY; SIDE EFFECT; SKIN MANIFESTATION; SOMNOLENCE; TREATMENT RESPONSE; VAGUS NERVE STIMULATION;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PIRACETAM; RETROSPECTIVE STUDIES; SEIZURES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 74349126332     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2009.01257.x     Document Type: Article

References (22)

1. Berkovic SF, Knowlton RC, Leroy RF et al. Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology 2007 69 : 1751 1760.
2. Noachtar S, Andermann E, Myevisch P et al. Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology 2008 70 : 607 616.
3. Abou-Khalil B, Lazenby B. Long-term experience with levetiracetam. Epileptic Disord 2003 53 : S33 37.
4. Betts T, Yarrow H, Greenhill L, Barrett M. Clinical experience of marketed levetiracetam in an epilepsy clinic - a one year follow up study. Seizure 2003 12 : 136 140.
5. Mohanraj R, Parker PG, Stephen LJ, Brodie MJ. Levetiracetam in refractory epilepsy: a prospective observational study. Seizure 2005 14 : 23 7.
6. Depondt C, Yuen AWC, Bell GS et al. The long term retention of levetiracetam in a large cohort of patients with epilepsy. J Neurol Neurosurg Psychiatry 2006 77 : 101 103.
7. Kuba R, Novotná I, Brázdil M et al. Long-term levetiracetam treatment of epilepsy patients: clinical audit. Epilepsy Res 2006 72 : 111 119.
8. Kaplan EL. Non-parametric estimation from incomplete observations. Am Stat Assoc J 1958 53 : 457 481.
9. Krakow K, Walker M, Otoul C, Sander JWAS. Long-term continuation of levetiracetam in patients with refractory epilepsy. Neurology 2001 56 : 1772 1774.
10. Ben-Menachem E, Edrich P, Van Vleymen B, Sander JWAS, Schmedt B. Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy. Epilepsy Res 2003 53 : 57 64.
11. Nicolson A, Lewis SA, Smith DF. A prospective analysis of the outcome of levetiracetam in clinical practice. Neurology 2004 63 : 568 570.
12. Abou-Khalil B, Schaich L. Long-term efficacy of levetiracetam for partial seizures. Seizure 2005 14 : 577 585.
13. Peltola J, Peltola M, Auvinen A et al. Clinical predictors in patients with refractory epilepsy exposed to levetiracetam: a single-center study. Acta Neurol Scand 2008 117 : 332 336.
14. Peltola J, Peltola M, Auvinen A, Raitanen J, Fallah M, Keränen T. Retention rates of new antiepileptic drugs in localization-related epilepsy: a single-center study. Acta Neurol Scand 2009 119 : 55 60.
15. Ben-Menachem E, Gilland E. Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy. Seizure 2003 12 : 131 135.
16. Ben-Menachem E, Falter U. Efficacy and tolerability of levetiracetam 3000mg in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. Epilepsia 2000 41 : 1276 1283.
17. Cereghino JJ, Biton V, Abou-Khalil B et al. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology 2000 55 : 236 242.
18. French J, Edrich P, Cramer JA. A systematic review of the safety profile of levetiracetam: a new antiepileptic drug. Epilepsy Res 2001 47 : 77 90.
19. Cramer JA, De Rue K, Devinsky O, Edrich P, Trimble MR. A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials. Epilepsy Behav 2003 4 : 124 132.
20. Brodtkorb E, Klees TM, Nakken KO et al. Levetiracetam in adult patients with and without learning disability: focus on behavioral adverse effects. Epilepsy Behav 2004 5 : 31 5.
21. Mula M, Trimble MR, Sander JW. Are psychiatric adverse events of antiepileptic drugs a unique entity? A study on topiramate and levetiracetam. Epilepsia 2007 48 : 2322 2326.
22. Legro B, Boon P, Dejonghe P, Sadzot B, Van Rijckevorsel K, Schmedding E. Opinion of Belgian neurologists on antiepileptic drugs: Belgian Study on Epilepsy Treatment (BESET). Acta Neurol Scand 2007 115 : 97 103.